lobbying_activities: 788506

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
788506	100352c9-e1e9-4c9f-97aa-9f9acd728a68	Q2	INVARIANT LLC	314237	ELI LILLY AND COMPANY	2009	second_quarter	MED	Support H.R. 1548, Pathway for Biosimilars Act; Oppose H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicine Act	HOUSE OF REPRESENTATIVES	80000		0	0	2009-07-14T17:17:05-04:00